Literature DB >> 10334474

Accurate determination of the number of CAG repeats in the Huntington disease gene using a sequence-specific internal DNA standard.

O Bruland1, E W Almqvist, Y P Goldberg, H Boman, M R Hayden, P M Knappskog.   

Abstract

We have developed a sequence-specific internal DNA size standard for the accurate determination of the number of CAG repeats in the Huntington disease (HD) gene by cloning key fragments (between 15 and 64 CAG repeats) of the HD gene. These fragments, pooled to produce a sequence-specific DNA ladder, enabled us to observe the true number of CAG repeats directly, with no need for calculations. Comparison of the calculated numbers of CAG repeats in the HD gene using this sequence-specific DNA standard with a commercially available standard (GENESCAN-500 TAMRA) showed that the latter underestimated the number of CAG repeats by three when analyzed by capillary electrophoresis on the ABI 310 Genetic Analyzer (POP4 polymer). In contrast, the use of the same standard overestimated the number of CAG repeats by one when the samples were analyzed by denaturing polyacrylamide electrophoresis on ABI 377 DNA Sequencer (6% denaturing polyacrylamide gel). This suggests that our sequence-specific standard provides greater accuracy for the determination of the true number of CAG repeats in the HD gene than commercially available standards. The sequence-specific standard can be radioactively labeled and successfully replace conventional DNA size standards when analyzing polymerase chain reaction (PCR)-amplified HD alleles by denaturing polyacrylamide electrophoresis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10334474     DOI: 10.1034/j.1399-0004.1999.550308.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  5 in total

1.  Diagnosis of five spinocerebellar ataxia disorders by multiplex amplification and capillary electrophoresis.

Authors:  Michael O Dorschner; Deborah Barden; Karen Stephens
Journal:  J Mol Diagn       Date:  2002-05       Impact factor: 5.568

2.  Indexing disease progression at study entry with individuals at-risk for Huntington disease.

Authors:  Ying Zhang; Jeffrey D Long; James A Mills; John H Warner; Wenjing Lu; Jane S Paulsen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-08-19       Impact factor: 3.568

3.  Caspase cleavage of mutant huntingtin precedes neurodegeneration in Huntington's disease.

Authors:  Cheryl L Wellington; Lisa M Ellerby; Claire-Anne Gutekunst; Danny Rogers; Simon Warby; Rona K Graham; Odell Loubser; Jeremy van Raamsdonk; Roshni Singaraja; Yu-Zhou Yang; Juliette Gafni; Dale Bredesen; Steven M Hersch; Blair R Leavitt; Sophie Roy; Donald W Nicholson; Michael R Hayden
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

4.  Improved high sensitivity screen for Huntington disease using a one-step triplet-primed PCR and melting curve assay.

Authors:  Mingjue Zhao; Felicia S H Cheah; Min Chen; Caroline G Lee; Hai-Yang Law; Samuel S Chong
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

5.  Towards a Joint International Database: Alignment of SSR Marker Data for European Collections of Cherry Germplasm.

Authors:  Matthew Ordidge; Suzanne Litthauer; Edward Venison; Marine Blouin-Delmas; Felicidad Fernandez-Fernandez; Monika Höfer; Christina Kägi; Markus Kellerhals; Annalisa Marchese; Stephanie Mariette; Hilde Nybom; Daniela Giovannini
Journal:  Plants (Basel)       Date:  2021-06-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.